Stephen J Gregson

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 3

Top Topics

Diffusion Weighted Imaging

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of medicinal chemistry

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Stephen J Gregson, Kathryn M Pugh, Neki Patel, Shameen Afif-Rider, Balakumar Vijayakrishnan, Kathleen Santos, Jitka Riedl, Ian Hutchinson, Gyoung-Dong Kang, K Phin Chooi, Rhiannon Beard, Lauren Adams, Conor S Barry, Kathryn Ball, Luke A Masterson, Mary McFarlane, John A Hartley, Philip W Howard
Efficacy, Tolerability, and Pharmacokinetic Studies of Antibody-Drug Conjugates Containing a Low-Potency Pyrrolobenzodiazepine Dimer. Molecular cancer therapeutics 21 (9) (2022)
Krista Kinneer, John Meekin, Arnaud C Tiberghien, Yu-Tzu Tai, Sandrina Phipps, Christine Mione Kiefer, Marlon C Rebelatto, Nazzareno Dimasi, Alyssa Moriarty, Kyriakos P Papadopoulos, Sriram Sridhar, Stephen J Gregson, Michael J Wick, Luke Masterson, Kenneth C Anderson, Ronald Herbst, Philip W Howard, David A Tice
SLC46A3 as a Potential Predictive Biomarker for Antibody-Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (24) (2018)
Stephen J Gregson, Luke A Masterson, Binqing Wei, Thomas H Pillow, Susan D Spencer, Gyoung-Dong Kang, Shang-Fan Yu, Helga Raab, Jeffrey Lau, Guangmin Li, Gail D Lewis Phillips, Janet Gunzner-Toste, Brian S Safina, Rachana Ohri, Martine Darwish, Katherine R Kozak, Josefa Dela Cruz-Chuh, Andrew Polson, John A Flygare, Philip W Howard
Pyrrolobenzodiazepine Dimer Antibody-Drug Conjugates: Synthesis and Evaluation of Noncleavable Drug-Linkers. Journal of medicinal chemistry 60 (23) (2017)